Search Results - "GLATZ, Y"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Effects of short‐term insulin‐like growth factor‐I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man by BIANDA, T., HUSSAIN, M. A., GLATZ, Y., BOUILLON, R., FROESCH, E. R., SCHMID, C.

    Published in Journal of internal medicine (01-02-1997)
    “…Objectives. To find out whether insulin‐like growth factor‐I (IGF‐I) mimics the stimulatory effects of growth hormone (GH) on bone turnover and renal tubular…”
    Get full text
    Journal Article
  2. 2

    Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans by Hussain, M A, Schmitz, O, Mengel, A, Glatz, Y, Christiansen, J S, Zapf, J, Froesch, E R

    Published in The Journal of clinical investigation (01-09-1994)
    “…Insulin-like growth factor-I (IGF-I) is considered to be the mediator of the growth-promoting effects of growth hormone (GH). The metabolic effects of these…”
    Get full text
    Journal Article
  3. 3

    Effects of short‐term insulin‐like growth factor‐I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D 3 production in healthy man by BIANDA, T., HUSSAIN, M. A., GLATZ, Y., BOUILLON, R., FROESCH, E. R., SCHMID, C.

    Published in Journal of internal medicine (01-02-1997)
    “…Objectives. To find out whether insulin‐like growth factor‐I (IGF‐I) mimics the stimulatory effects of growth hormone (GH) on bone turnover and renal tubular…”
    Get full text
    Journal Article
  4. 4

    Improvement of lipid profile in Type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I by ZENOBI, P. D, HOLZMANN, P, GLATZ, Y, RIESEN, W. F, FROESCH, E. R

    Published in Diabetologia (01-05-1993)
    “…Type 2 (non-insulin-dependent) diabetes mellitus is associated with increased glucose, insulin, total and VLDL-triglyceride, and often total and…”
    Get full text
    Journal Article
  5. 5

    Insulin-like growth factor-I in man enhances lipid mobilization and oxidation induced by a growth hormone pulse by Bianda, T L, Hussain, M A, Keller, A, Glatz, Y, Schmitz, O, Christiansen, J S, Alberti, K G, Froesch, E R

    Published in Diabetologia (01-08-1996)
    “…Growth hormone (GH) secretion is suppressed during insulin-like growth factor-I (IGF-I) administration. The aim of the study was to examine whether IGF-I…”
    Get full text
    Journal Article
  6. 6

    Beneficial metabolic effects of insulin-like growth factor I in patients with severe insulin-resistant diabetes type A by Zenobi, P D, Glatz, Y, Keller, A, Graf, S, Jaeggi-Groisman, S E, Riesen, W F, Schoenle, E J, Froesch, E R

    Published in European journal of endocrinology (01-09-1994)
    “…Severe insulin resistance type A is due to mutations in the insulin receptor gene and is characterized by glucose intolerance or diabetes mellitus, despite…”
    Get more information
    Journal Article
  7. 7
  8. 8

    Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure by DONATH, M. Y, SÜTSCH, G, YAN, X.-W, PIVA, B, BRUNNER, H.-P, GLATZ, Y, ZAPF, J, FOLLATH, F, FROESCH, E. R, KIOWSKI, W

    “…Insulin-like growth factor I (IGF-I) enhances myofibrillar development in cardiomyocytes of rats in culture and in vivo. In addition, IGF-I has vasodilatory…”
    Get full text
    Journal Article
  9. 9

    Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults by BIANDA, T, GLATZ, Y, BOUILLON, R, FROESCH, E. R, SCHMID, C

    “…Administration of insulin-like growth factor-I (IGF-I) or growth hormone (GH) is known to stimulate bone turnover and kidney function. To investigate the…”
    Get full text
    Journal Article
  10. 10

    Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans by DONATH, M. Y, JENNI, R, BRUNNER, H.-P, ANRIG, M, KOHLI, S, GLATZ, Y, FROESCH, E. R

    “…To determine whether insulin-like growth factor I (IGF-I) has systemic cardiovascular effects in humans, 60 micrograms/kg IGF-I or saline were injected sc in a…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13